Pfizer is going to fight to keep doctors from switching to generic simvastatin. In the majority of cases, simvastatin will do just fine.
More in Uncategorized
Past Week
-
Medicine’s struggle for inclusivity
-
Venture-backed telemental health care companies are creating a new opioid epidemic
-
Your A+ in anatomy and physiology won’t improve the American health care system
-
Unworthiness nearly killed me
-
A doctor’s struggle for patient care
-
Breaking free from denial: Embracing the truth
-
Past 6 Months
-
Real pain deserves real treatment
-
Medicine’s struggle for inclusivity
-
Medicine is not apolitical: Your vote dictates your ability to practice medicine
-
Venture-backed telemental health care companies are creating a new opioid epidemic
-
Elite access vs. public scrutiny: Medication disparities exposed
-
Your A+ in anatomy and physiology won’t improve the American health care system
-
Recent Posts
-
Physician autonomy with self-employment [PODCAST]
-
Navigating grief and stress: Embracing catharsis
-
Apple’s OpenGL and iOS 18: Shaping the future of health care technology
-
Tips and tricks for presenting research at a medical conference as a premed
-
A doctor’s struggle for patient care
-
AI in American medicine [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
